Monoacylglycerol Lipase Inhibition in Human and Rodent Systems Supports Clinical Evaluation of Endocannabinoid Modulators.

Autor: Clapper JR; Abide Therapeutics, San Diego, California., Henry CL; Abide Therapeutics, San Diego, California., Niphakis MJ; Abide Therapeutics, San Diego, California., Knize AM; Abide Therapeutics, San Diego, California., Coppola AR; Abide Therapeutics, San Diego, California., Simon GM; Abide Therapeutics, San Diego, California., Ngo N; Abide Therapeutics, San Diego, California., Herbst RA; Abide Therapeutics, San Diego, California., Herbst DM; Abide Therapeutics, San Diego, California., Reed AW; Abide Therapeutics, San Diego, California., Cisar JS; Abide Therapeutics, San Diego, California., Weber OD; Abide Therapeutics, San Diego, California., Viader A; Abide Therapeutics, San Diego, California., Alexander JP; Abide Therapeutics, San Diego, California., Cunningham ML; Abide Therapeutics, San Diego, California., Jones TK; Abide Therapeutics, San Diego, California., Fraser IP; Abide Therapeutics, San Diego, California., Grice CA; Abide Therapeutics, San Diego, California., Ezekowitz RAB; Abide Therapeutics, San Diego, California., O'Neill GP; Abide Therapeutics, San Diego, California., Blankman JL; Abide Therapeutics, San Diego, California jackie@abidetx.com.

Publikováno v: The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2018 Dec; Vol. 367 (3), pp. 494-508. Date of Electronic Publication: 2018 Oct 10.